ENTRY       hsa05030                    Pathway
NAME        Cocaine addiction - Homo sapiens (human)
DESCRIPTION Drug addiction is a chronic, relapsing disorder in which compulsive drug-seeking and drug-taking behavior persists despite serious negative consequences.There is strong evidence that the dopaminergic system that projects from the ventral tegmental area (VTA) of the midbrain to the nucleus accumbens (NAc), and to other forebrain sites, is the major substrate of reward and reinforcement for both natural rewards and addictive drugs. Cocaine binds strongly to the dopamine-reuptake transporter, preventing the reuptake of dopamine into the nerve terminal. Because of this blocking effect, dopamine remains at high concentrations in the synapse and continues to affect adjacent neurons, producing the characteristic cocaine "high." Activated D1 receptor activates the PKA signaling pathway, and this pathway plays a critical role in mediating the behavioral responses to cocaine administration. Cocaine-induced neuroadaptations, including dopamine depletion, may underlie craving and hedonic dysregulation.
CLASS       Human Diseases; Substance dependence
PATHWAY_MAP hsa05030  Cocaine addiction
DRUG        D00110  Cocaine (USP)
            D02182  Cocaine hydrochloride (JP18/USP)
            D05663  Pyrovalerone hydrochloride (USAN)
DBLINKS     GO: 0042220
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        1020  CDK5; cyclin dependent kinase 5 [KO:K02090] [EC:2.7.11.22]
            10488  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
            111  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
            116443  GRIN3A; glutamate ionotropic receptor NMDA type subunit 3A [KO:K05213]
            116444  GRIN3B; glutamate ionotropic receptor NMDA type subunit 3B [KO:K05214]
            1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
            1386  ATF2; activating transcription factor 2 [KO:K04450]
            1388  ATF6B; activating transcription factor 6 beta [KO:K09049]
            148327  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
            1644  DDC; dopa decarboxylase [KO:K01593] [EC:4.1.1.28 4.1.1.105]
            1742  DLG4; discs large MAGUK scaffold protein 4 [KO:K11828]
            1812  DRD1; dopamine receptor D1 [KO:K04144]
            1813  DRD2; dopamine receptor D2 [KO:K04145]
            2354  FOSB; FosB proto-oncogene, AP-1 transcription factor subunit [KO:K09029]
            26086  GPSM1; G protein signaling modulator 1 [KO:K15839]
            2770  GNAI1; G protein subunit alpha i1 [KO:K04630]
            2771  GNAI2; G protein subunit alpha i2 [KO:K04630]
            2773  GNAI3; G protein subunit alpha i3 [KO:K04630]
            2778  GNAS; GNAS complex locus [KO:K04632]
            2891  GRIA2; glutamate ionotropic receptor AMPA type subunit 2 [KO:K05198]
            2902  GRIN1; glutamate ionotropic receptor NMDA type subunit 1 [KO:K05208]
            2903  GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209]
            2904  GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210]
            2905  GRIN2C; glutamate ionotropic receptor NMDA type subunit 2C [KO:K05211]
            2906  GRIN2D; glutamate ionotropic receptor NMDA type subunit 2D [KO:K05212]
            2912  GRM2; glutamate metabotropic receptor 2 [KO:K04605]
            2913  GRM3; glutamate metabotropic receptor 3 [KO:K04606]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            4128  MAOA; monoamine oxidase A [KO:K00274] [EC:1.4.3.4]
            4129  MAOB; monoamine oxidase B [KO:K00274] [EC:1.4.3.4]
            468  ATF4; activating transcription factor 4 [KO:K04374]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            5173  PDYN; prodynorphin [KO:K15840]
            5566  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
            5567  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
            5568  PRKACG; protein kinase cAMP-activated catalytic subunit gamma [KO:K04345] [EC:2.7.11.11]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            627  BDNF; brain derived neurotrophic factor [KO:K04355]
            64764  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
            6531  SLC6A3; solute carrier family 6 member 3 [KO:K05036]
            6570  SLC18A1; solute carrier family 18 member A1 [KO:K08155]
            6571  SLC18A2; solute carrier family 18 member A2 [KO:K08155]
            7054  TH; tyrosine hydroxylase [KO:K00501] [EC:1.14.16.2]
            84152  PPP1R1B; protein phosphatase 1 regulatory inhibitor subunit 1B [KO:K15494]
            84699  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]
            8787  RGS9; regulator of G protein signaling 9 [KO:K13765]
            8851  CDK5R1; cyclin dependent kinase 5 regulatory subunit 1 [KO:K11716]
            90993  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
            9586  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
COMPOUND    C00025  L-Glutamate
            C00027  Hydrogen peroxide
            C00082  L-Tyrosine
            C00355  3,4-Dihydroxy-L-phenylalanine
            C00575  3',5'-Cyclic AMP
            C01161  3,4-Dihydroxyphenylacetate
            C03758  Dopamine
            D00110  Cocaine (USP)
REFERENCE   PMID:16278489
  AUTHORS   Ron D, Jurd R
  TITLE     The "ups and downs" of signaling cascades in addiction.
  JOURNAL   Sci STKE 2005:re14 (2005)
            DOI:10.1126/stke.3092005re14
REFERENCE   PMID:18440072
  AUTHORS   Cunha-Oliveira T, Rego AC, Oliveira CR
  TITLE     Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
  JOURNAL   Brain Res Rev 58:192-208 (2008)
            DOI:10.1016/j.brainresrev.2008.03.002
REFERENCE   PMID:19403004
  AUTHORS   Chen JC, Chen PC, Chiang YC
  TITLE     Molecular mechanisms of psychostimulant addiction.
  JOURNAL   Chang Gung Med J 32:148-54 (2009)
REFERENCE   PMID:16251986
  AUTHORS   Nestler EJ
  TITLE     Is there a common molecular pathway for addiction?
  JOURNAL   Nat Neurosci 8:1445-9 (2005)
            DOI:10.1038/nn1578
REFERENCE   PMID:15091342
  AUTHORS   Bowers MS, McFarland K, Lake RW, Peterson YK, Lapish CC, Gregory ML, Lanier SM, Kalivas PW
  TITLE     Activator of G protein signaling 3: a gatekeeper of cocaine sensitization and drug seeking.
  JOURNAL   Neuron 42:269-81 (2004)
            DOI:10.1016/S0896-6273(04)00159-X
REFERENCE   PMID:12818179
  AUTHORS   Rahman Z, Schwarz J, Gold SJ, Zachariou V, Wein MN, Choi KH, Kovoor A, Chen CK, DiLeone RJ, Schwarz SC, Selley DE, Sim-Selley LJ, Barrot M, Luedtke RR, Self D, Neve RL, Lester HA, Simon MI, Nestler EJ
  TITLE     RGS9 modulates dopamine signaling in the basal ganglia.
  JOURNAL   Neuron 38:941-52 (2003)
            DOI:10.1016/S0896-6273(03)00321-0
REFERENCE   PMID:10234039
  AUTHORS   Horger BA, Iyasere CA, Berhow MT, Messer CJ, Nestler EJ, Taylor JR
  TITLE     Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor.
  JOURNAL   J Neurosci 19:4110-22 (1999)
            DOI:10.1523/JNEUROSCI.19-10-04110.1999
REFERENCE   PMID:12064476
  AUTHORS   Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S
  TITLE     Dopamine transport function is elevated in cocaine users.
  JOURNAL   J Neurochem 81:292-300 (2002)
            DOI:10.1046/j.1471-4159.2002.00820.x
REFERENCE   PMID:14566342
  AUTHORS   McClung CA, Nestler EJ
  TITLE     Regulation of gene expression and cocaine reward by CREB and DeltaFosB.
  JOURNAL   Nat Neurosci 6:1208-15 (2003)
            DOI:10.1038/nn1143
REFERENCE   PMID:15582154
  AUTHORS   McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ
  TITLE     DeltaFosB: a molecular switch for long-term adaptation in the brain.
  JOURNAL   Brain Res Mol Brain Res 132:146-54 (2004)
            DOI:10.1016/j.molbrainres.2004.05.014
REFERENCE   PMID:11595774
  AUTHORS   Ang E, Chen J, Zagouras P, Magna H, Holland J, Schaeffer E, Nestler EJ
  TITLE     Induction of nuclear factor-kappaB in nucleus accumbens by chronic cocaine administration.
  JOURNAL   J Neurochem 79:221-4 (2001)
            DOI:10.1046/j.1471-4159.2001.00563.x
REFERENCE   PMID:11268215
  AUTHORS   Bibb JA, Chen J, Taylor JR, Svenningsson P, Nishi A, Snyder GL, Yan Z, Sagawa ZK, Ouimet CC, Nairn AC, Nestler EJ, Greengard P
  TITLE     Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.
  JOURNAL   Nature 410:376-80 (2001)
            DOI:10.1038/35066591
REFERENCE   PMID:14746512
  AUTHORS   Chao J, Nestler EJ
  TITLE     Molecular neurobiology of drug addiction.
  JOURNAL   Annu Rev Med 55:113-32 (2004)
            DOI:10.1146/annurev.med.55.091902.103730
REL_PATHWAY hsa04728  Dopaminergic synapse
KO_PATHWAY  ko05030
///
